For more than 30 years, the lung transplant team at UPMC has been dedicated to improving both the quantity and quality of life for many patients suffering from end-stage lung disease. This past year, the UPMC Lung Transplant Program celebrated the 2,000th lung transplant since the program’s inception in 1982. Ours is the first program in the U.S. to achieve this volume of transplants while maintaining survival outcomes that are comparable to national averages. As a result of this experience, approximately 30% of patients transplanted at UPMC were previously evaluated and declined at other lung transplant programs across the world.
Educational objectives:
Upon completion of this activity, participants should be able to:
- Describe some of the patients that may be considered candidates at UPMC that may be declined for lung transplantation at other institutions.
- Name some of the recent technologies in the field of lung transplantation that are being used by the UPMC lung transplant team.
- Increase recognition of potential contraindications/complicating factors in patients being considered for referral for lung transplant evaluation
- Increase evaluation and management of modifiable risk factors affecting a patient's potential candidacy for lung transplant evaluation
Disclosures:
Drs. Morrell, Pipeling, Robinson, Nolley, Pilewski, and Naik have reported no relevant relationships with entities producing health care goods or services
Dr. Mallampall has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Consultant: Consultant and Co-founder, Koutif, Inc.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement:
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to .5 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
